Before 2007, the research community had dogmatically insisted
that only embryonic stem
cell research would be medically useful, and that adult stem cell research was a waste of resources and effort.
The contentious debate was framed as between "enlightened" scientists and
religious fundamentalists.
If the viability of using
adult stem cells to repair damaged tissue--including damaged brain cells--is proven--without
unforeseen disastrous consequences-- then we will have resolved both the moral concerns
of a significant segment of the population, as well eliminating the complex,
high risk medical issues involved in transplanting organs or embryonic stem
cells.
Existing stem cells in the adult brain stimulated by drug to repair brain
damage in animal models of multiple sclerosis Dr. Eva Sirinathinghji
There has been a great deal of excitement over the recent discovery that
stem cells (see Box) with the potential to multiply indefinitely and generate
many other different kinds of cells can be created from ordinary skin cells
(see [1] The
Promise of Induced Pluripotent Stem Cells, SiS 50). These ‘induced
pluripotent stem cells’ (iPS cells) could be used to repair damaged tissue. For
example, they can be turned into the types of brain cells – cholinergic
neurones – that are thought to die early on in Alzheimer’s disease [2].
Although iPS cells may be useful for modelling diseases, their potential for
regenerative therapy, as with embryonic stem cells, is still limited. The
dangers of tumour formation following transplantation, as well as the
requirement for brain surgery, on top of the little evidence of success in animal
and human studies, are some of the major concerns regarding stem cell therapies
for brain diseases.
In contrast to the use of exogenous stem cells for brain repair, researchers
at Edinburgh and Cambridge Universities in the UK reported earlier that naturally
existing stem cells in the adult brain can be stimulated by a drug to repair
damage in animal models of multiple sclerosis (MS) [3].
This proof-of-principle experiment suggest that there is little scientific
advantage in deriving embryonic cells for tissue repair when naturally existing
adult stem cells can do the job, with minimum intervention and without raising
ethical concerns (see [4] No Case
for Embryonic Stem Cells Research, and other articles in the series, SiS
25).
Stem cells for therapy
Since the first derivation of human embryonic stem (hES) cells in 1998
[5], stem cell therapies have been investigated for a wide range of
medical conditions from heart disease, diabetes, spinal cord injury, retinal
disorders, stroke, as well as neurodegenerative diseases including Parkinson’s,
Huntington’s disease and MS. A great deal of research to date has focused on
the use of embryonic stem cells derived from human embryos for regenerative
repair; though clinical success has only been reported for using the patient’s
own adult stem cells (see [6] Patient's
Own Stem Cells Mend Heart, SiS 25).
More recently, however, research based on utilising endogenous brain stem
cells (a person’s own cells) has gained ground. Such a strategy can avoid all
ethical issues associated with deriving stem cells from embryos. It also avoids
the scientific complications of using embryonic cells grown in long-term
culture, where their full cellular identity and capacity to differentiate into
different kinds of cells, migrate and functionally integrate into patients
bodies is still limited or unknown. Embryonic stem cell cultures are also
notoriously unstable, showing genetic imbalances over time, and also have
potential to develop into tumours [3]. Furthermore, stem cell transplantation
can require serious surgical procedures that are risky and expensive. Surgery
on the brain would be best avoided under any circumstances, considering it is
the most complicated, as well as least understood organ in our body.
This is an exciting approach to regenerative repair, and could be applied to
many different diseases, not just those affecting the brain. Work on heart disease
has also made progress in this area, where a recent paper showing that
haematopoietic stem cells produced in adult bone marrow, can be
pharmacologically manipulated to repair heart tissue following myocardial
infarction (heart attack) in mice [9]. By giving a molecule to the mice that
mobilised stem cells from the bone marrow into blood circulation, along with a
drug to protect its degradation, the stem cells were able to successfully reach
the heart. This work led to generation of new blood vessels, improved cardiac
function, and increased survival, offering hope in treating one of the biggest
killers in the world, safely and affordably.
Adult stem cells are showing greater and greater promise in providing a more
ethical alternative to embryonic stem cells. With the discovery of more and
more resident stem cells in various adult tissues, the future lies with being
able to utilise these cells to perform the job that, ultimately, they are
perfectly designed to do.
A fully
referenced version of this article is posted on ISIS members website and is
available for download here